-
UNC Doctors, Students Collaborate on COVID Treatment Study
-
In the first COVID-19 case series of tocilizumab in the United States, UNC-Chapel Hill researchers and students from the UNC School of Medicine and Gillings School of Global Public Health, report that the drug tocilizumab should be used judiciously until randomized clinical trials determine the drug’s true efficacy for severely ill patients.
Located in
Vital Signs
/
2020
/
May 21
-
Long-Acting Injectable Cabotegravir Highly Effective at Preventing HIV Infection
-
The global randomized, controlled and double-blinded study, co-led by Myron Cohen, MD, showed that the drug cabotegravir lowered HIV incidence among cisgender men and transgender women who have sex with men.
Located in
News
/
2020
/
May
-
UNC, NC State Biomedical engineers speed the development of emergency ventilator
-
Biomedical engineers at UNC-Chapel Hill and NC State responded to the COVID-19 Pandemic by teaming with UNC Health colleagues to create emergency ventilators.
Located in
Vital Signs
/
2020
/
May 14
-
Glenn Leads Global Health Initiatives in Pediatric Nephrology
-
Dorey Glenn, MD, MPH, promotes global volunteerism in pediatric nephrology to address kidney disease.
Located in
Vital Signs
/
2020
/
May 7
-
Rivera Appointed Secretary-Treasurer of ATS, President in 2023
-
Patricia Rivera, MD, ATSF, professor of medicine in the division of pulmonary and critical care medicine, has been elected the secretary-treasurer of the American Thoracic Society (ATS) and will serve as president of the organization in 2023.
Located in
Vital Signs
/
2020
/
May 7
-
Novel Primary Care Model Promotes Lifelong Comprehensive Care for People Living with HIV
-
Shana Ratner, MD, associate professor in the division of general medicine, and section chief for education and clinical practice, announces a new collaboration with the division of infectious diseases that includes a multidisciplinary primary care clinic to serve people living with HIV. The new model lays the groundwork for multidisciplinary care in advance of department of medicine clinics' move to Eastowne.
Located in
Vital Signs
/
2020
/
May 7
-
Fischer, Lazear Named Winners of the Jefferson-Pilot Fellowships
-
William Fischer, MD, and Helen Lazear, PhD, earned Jefferson-Pilot Fellowships in Academic Medicine from the UNC School of Medicine for their infectious diseases research and clinical care.
Located in
Vital Signs
/
2020
/
May 7
-
Basch Co-authors Cancer Treatment Guidance in JAMA
-
Ethan Basch, MD, MSc., division chief of oncology at the UNC School of Medicine and a UNC Lineberger member, has detailed cancer treatment guidance to balance cancer patients’ treatment and infection risk in light of the COVID-19 pandemic.
Located in
Vital Signs
/
2020
/
April 23
-
UNC Receives NIH Diabetes Research Center Grant with Partner Institutions
-
John Buse, MD, PhD, will lead the UNC site in a $5.7 million diabetes research collaboration with Duke, Wake Forest, and NC A&T, funded through the National Institutes of Health.
Located in
News
/
2020
/
April
-
Serody, Basch Will Lead Divisions in Realignment of Hematology and Oncology
-
Jonathan Serody, MD, director of UNC’s Bone Marrow Transplantation & Cellular Therapy Program, is the new division chief for hematology. Ethan Basch, MD, the Richard M. Goldberg Distinguished Professor in Medical Oncology, is the new division chief for oncology. Both are members of the UNC Lineberger Comprehensive Cancer Center.
Located in
Vital Signs
/
2020
/
April 16